GMP Violations Are A Consistent But Well-Shuffled Deck, FDA Data Show
Executive Summary
The same five sets of cGMP violations have shown up for at least the past five fiscal years when FDA inspects drug manufacturers, according to a database the agency recently made public.
You may also be interested in...
Industry Compliance Data Should Be Linked To Enforcement Results, FDA Transparency Taskforce Says
FDA's website should resemble EPA's and Department of Labor's, report concludes.
In Brief
CDER reorganizes for global compliance
In Brief
CDER reorganizes for global compliance